Present and Future Prospects of the Anti-cancer Activities of Saikosaponins
Author:
Affiliation:
1. Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, China
2. Second College of Clinical Medicine, Lanzhou University, Lanzhou, China
Abstract
Funder
Science and Technology Program of Gansu Province, China
Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital, China
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Drug Discovery,Pharmacology,Oncology
Reference77 articles.
1. Yang S.M.; Huang C.; Li X.F.; Yu M.Z.; He Y.; Li J.; miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology 2013,306,162-168
2. Panda M.; Biswal B.K.; Cell signaling and cancer: A mechanistic insight into drug resistance. Mol Biol Rep 2019,46(5),5645-5659
3. Yang F.; Dong X.; Yin X.; Wang W.; You L.; Ni J.; Radix bupleuri: A review of traditional uses, botany, phytochemistry, pharmacology, and toxicology. BioMed Res Int 2017,2017,7597596
4. Cheng T.; Ying M.; Antitumor effect of saikosaponin A on human neuroblastoma cells. BioMed Res Int 2021,2021,5845554
5. Luo J.; Wang J.; Yang J.; Huang W.; Liu J.; Tan W.; Xin H.; Saikosaponin B1 and Saikosaponin D inhibit tumor growth in medullo-blastoma allograft mice via inhibiting the Hedgehog signaling pathway. J Nat Med 2022,76(3),584-593
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Online ligand screening for cytochrome C from herbal medicines through “four-in-one” measurement;Pharmacological Research;2024-09
2. Effects of total saikosaponins on CYP3A4 and CYP1A2 in HepaRG cells;Experimental and Therapeutic Medicine;2024-03-21
3. Quantitative and Differential Analysis between Bupleurum chinense DC. and Bupleurum scorzonerifolium Willd. Using HPLC-MS and GC-MS Coupled with Multivariate Statistical Analysis;Molecules;2023-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3